The KUB-2E can be paired with Kalashnikov's SKAT-350M reconnaissance UAV in a swarm attack, with the SKAT-350M relaying target co-ordinates and data to the KUB-2E for a strike, said Kalashnikov.

ZIM Integrated Shipping tumbles more than 10% in two days since reporting Q4 and full-year results. Fearnley Securities ...

Bengaluru: In the world of aerobatic aviation, few teams command as much respect as the Indian Air Force's Surya Kiran Aerobatics Team (Skat). Among its elite pilots is Group Captain Sidhesh ...

The Department of Education last week said it canceled nearly $350 million in "woke" spending, purportedly addressing the most pressing problems of education policy and practice. The agency ...

Everton have agreed a £350million ($450m) refinancing package for their new stadium. The funding, sources with knowledge of the process say, has been arranged by the U.S. financial services ...

AbbVie is paying $350 million to join the obesity race. The outlay, plus up to $1.87 billion in milestones, has landed the drugmaker rights to a long-acting amylin analog that is in phase 1 ...

You have /5 articles left. Sign up for a free account or log in. The U.S. Education Department has canceled 10 contracts with Regional Educational Laboratories ...

The Blues have secured a long-term, £350m funding deal that rearranges the lending already in place on the waterfront venue. The move means the remaining debt has been simplified from complex ...

“We announced today that our Board of Directors approved a $350 million increase to the Share Repurchase Program authorization. As of today, $450 million remained available under the Share ...

Real Madrid unsurprisingly want to keep the left-winger for the long-run but we understand that Saudi could test their resolve with a bid as high as €350m (£290m, $365m) for Vinicius Jr THIS ...

President and CEO Katherine Stueland stated that GeneDx achieved significant milestones in 2024, including surpassing $95 million in Q4 revenue and expanding gross margins to 70%. She highlighted ...

AbbVie is joining the chase for new obesity drugs, but rather than getting a me-too GLP-1 drug, the pharmaceutical giant is landing rights to a clinical-stage molecule that goes after two novel ...